Novartis Finland Oy is a limited company based in Espoo, registered in 1966. Its taxable income in 2024 was 4,6 M€ and its income taxes 919 t€. Public buyers bought 460 t€ from it in 2024–2024; the largest buyer is Sairaanhoidolliset Palvelut (Pohjois-Pohjanmaan hyvinvointialue). It has won 2 public contracts in EU procurement notices.
Taxes
Measured by taxable income, Novartis Finland Oy is in the top 10 % of the industry class wholesale of pharmaceutical goods (82 companies with taxable income; median 603 t€, 7,6 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026. Revenue, financial ratios and employee numbers are shown once the company has filed its financial statements digitally.
Sales to public buyers
Largest buyers
Public contracts won
- Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotilailleHUS Group, the joint authority for Helsinki and Uusimaa, Varsinais-Suomen hyvinvointialue, Pirkanmaan hyvinvointialue, Pohjois-Pohjanmaan hyvinvointialue2,0 M€
- CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2026 – 31.12.2027HUS Group, the joint authority for Helsinki and Uusimaa, Varsinais-Suomen hyvinvointialue, Pohjois-Pohjanmaan hyvinvointialue (3221326-2), Pirkanmaan hyvinvointialue20,0 M€
Free monthly list: Espoo
Once a month by email: new leads in this municipality and its neighbours, the month's figures and the full list. No charge, no commitment, cancel any time.
Follow companies in your area
New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.
Try for free